CIR CIR S.p.A. - Compagnie Industriali Riunite
CIR S.p.A. - Compagnie Industriali Riunite, through its subsidiaries, operates in the automotive components and healthcare sectors in Italy, the rest of European countries, North America, South America, Asia, and internationally. The company produces suspension components, including coil springs, stabilizer bars, torsion bars, stabilinks, leaf springs, track adjusters, and precision springs; and intake manifolds, air ducts, coolant pumps, engine temperature management systems, and new advanced solutions for thermal management. It also operates Nursing Homes under the Anni Azzurri and Charleston brands; Healthcare Facilities providing medical care for functional rehabilitation under the Santo Stefano brand, as well as medical care and rehabilitation for mental health under the Neomesia brand; and hospital for acute care under the Villa dei Pini brand. In addition, the company operates a network of outpatient clinics, such as virtual clinics, telemedicine, and home care. CIR S.p.A. - Compagnie Industriali Riunite was founded in 1976 and is headquartered in Milan, Italy.…
Industry Peers
Auto PartsKey Statistics
About CIR S.p.A. - Compagnie Industriali Riunite (BIT: CIR)
›
CIR S.p.A. - Compagnie Industriali Riunite (BIT: CIR) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Auto Parts industry, part of the Consumer Cyclical sector, and reports about 15,101 employees.
The shares were at 0.7590 EUR on 19 November 2026, up 10.5% over 52 weeks. Its 52-week range is 0.6390 EUR to 0.8010 EUR: the price is 5.2% below the high and 18.8% above the low.
At a market capitalisation of 624.44M EUR, it trades at 10.8 times trailing earnings and 10.3 times forward earnings. The median trailing P/E of its 17 largest Auto Parts peers is 19.7, a discount of 45% for CIR.
CIR S.p.A. - Compagnie Industriali Riunite reports return on equity of 3.6%, an operating margin of 6.5% and revenue up 1.7% year over year.
Its debt exceeds its cash by 777.05M EUR, a debt-to-equity ratio of 1.32. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 0.8713 EUR is 14.8% above the current price.